Analysts Set Ardent Health Partners, LLC (NYSE:ARDT) Price Target at $22.00

Ardent Health Partners, LLC (NYSE:ARDT) has been assigned an average recommendation of “Buy” from the twelve brokerages that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $22.00.

Several equities research analysts have recently weighed in on the stock. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Stephens reissued an “overweight” rating and issued a $24.00 price objective on shares of Ardent Health Partners in a research note on Thursday, September 19th. KeyCorp began coverage on Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 target price for the company. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Finally, Bank of America cut shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $22.00 to $19.00 in a report on Wednesday, November 6th.

Ardent Health Partners Stock Up 1.8 %

Ardent Health Partners stock opened at $16.09 on Thursday. The business has a 50 day moving average of $16.53. Ardent Health Partners has a one year low of $14.57 and a one year high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Institutional Investors Weigh In On Ardent Health Partners

Institutional investors and hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets bought a new stake in Ardent Health Partners in the third quarter valued at $42,000. Financial Management Professionals Inc. purchased a new position in shares of Ardent Health Partners in the 3rd quarter valued at approximately $50,000. MetLife Investment Management LLC purchased a new stake in Ardent Health Partners in the third quarter worth $135,000. JPMorgan Chase & Co. purchased a new position in Ardent Health Partners during the third quarter valued at $154,000. Finally, Quadrature Capital Ltd bought a new stake in shares of Ardent Health Partners during the 3rd quarter valued at $229,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.